Amneal Pharmaceuticals, Inc.
AMRX stock score: 65/100
$20.20 · +1.81% · Scored Oct 21, 2026
- Technical
- 72
- Fundamental
- 59
- News
- —
The reading
Amneal Pharmaceuticals (AMRX) scores 65 out of 100, which reads neutral, higher than 94% of Healthcare stocks and 90% of the 4,166 US stocks we score.
The composite is technicals and fundamentals weighted equally: technicals read 72, fundamentals 59.
Among the fundamentals, Return on Equity (ROE) at 100 and Earnings Growth (Annual) at 100 score highest, while Price to Book Ratio at 0 weighs the most against it.
On the daily chart, trend-following indicators average 67 and contrarian oscillators 43.
Since Jul 25, 2026 the composite has ranged from 60 to 74, and it is down 1 point over the period.
What’s driving the score
The strongest and weakest of the scorers that count toward AMRX’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.
Fundamental
59Pulling it up
- Return on Equity (ROE)100
Return on Equity (ROE) measures how efficiently a company generates profits from shareholder equity.
- Earnings Growth (Annual)100
Annual earnings growth tracks year-over-year profit expansion.
- Earnings Growth (Quarterly)100
Quarterly earnings growth measures profit increase versus the prior-year quarter.
Holding it back
- Price to Book Ratio0
Price-to-Book ratio compares market value to book value.
- Debt to Equity0
Debt-to-Equity ratio measures financial leverage by comparing total debt to shareholder equity.
- Gross Margins3
Gross margins show profitability after cost of goods sold.
40 weighted scorers; 1 had no data today and are left out rather than counted as zero.
Technical · daily
66Pulling it up
- EMA 200100
Exponential Moving Average (200-period) is a crucial long-term trend indicator that reacts faster than SMA-200.
- Ichimoku Cloud100
Ichimoku Cloud is a comprehensive indicator showing support/resistance, trend direction, and momentum.
- 52-Week Change100
The price change over the last 52 weeks.
Holding it back
- Parabolic SAR (PSAR)0
Parabolic SAR (Stop and Reverse) provides trailing stop levels that follow price trends.
- Bollinger Bands (50)17
Bollinger Bands (50-period) measure where price sits between bands two standard deviations around its 50-period average.
- SMA 200 Cross Up24
SMA 200 Cross Up tracks when faster moving averages cross above the 200-period SMA.
62 weighted scorers; 3 had no data today and are left out rather than counted as zero.
Technical score by timeframe
| Chart | Score | Weight |
|---|---|---|
| Hourly | 59 | 1 |
| Daily | 66 | 3 |
| Weekly | 73 | 2 |
| Monthly | 75 | 2 |
| Quarterly | 81 | 2 |
Composite score, last 90 days
Show the daily numbers
| Date | Composite |
|---|---|
| Oct 21, 2026 | 65 |
| Oct 20, 2026 | 65 |
| Oct 19, 2026 | 63 |
| Oct 18, 2026 | 64 |
| Oct 17, 2026 | 64 |
| Oct 16, 2026 | 64 |
| Oct 15, 2026 | 62 |
| Oct 14, 2026 | 62 |
| Oct 13, 2026 | 63 |
| Oct 12, 2026 | 65 |
| Oct 11, 2026 | 65 |
| Oct 10, 2026 | 65 |
| Oct 9, 2026 | 65 |
| Oct 8, 2026 | 64 |
| Oct 7, 2026 | 64 |
| Oct 6, 2026 | 65 |
| Oct 5, 2026 | 66 |
| Oct 4, 2026 | 66 |
| Oct 3, 2026 | 66 |
| Oct 2, 2026 | 66 |
| Oct 1, 2026 | 66 |
| Sep 30, 2026 | 65 |
| Sep 29, 2026 | 66 |
| Sep 28, 2026 | 66 |
| Sep 27, 2026 | 66 |
| Sep 26, 2026 | 66 |
| Sep 25, 2026 | 66 |
| Sep 24, 2026 | 66 |
| Sep 23, 2026 | 66 |
| Sep 22, 2026 | 66 |
| Sep 21, 2026 | 66 |
| Sep 20, 2026 | 66 |
| Sep 19, 2026 | 66 |
| Sep 18, 2026 | 66 |
| Sep 17, 2026 | 65 |
| Sep 16, 2026 | 65 |
| Sep 15, 2026 | 61 |
| Sep 14, 2026 | 63 |
| Sep 13, 2026 | 62 |
| Sep 12, 2026 | 62 |
| Sep 11, 2026 | 62 |
| Sep 10, 2026 | 61 |
| Sep 9, 2026 | 63 |
| Sep 8, 2026 | 63 |
| Sep 7, 2026 | 63 |
| Sep 6, 2026 | 63 |
| Sep 5, 2026 | 63 |
| Sep 4, 2026 | 62 |
| Sep 3, 2026 | 65 |
| Sep 2, 2026 | 65 |
| Sep 1, 2026 | 64 |
| Aug 31, 2026 | 62 |
| Aug 30, 2026 | 63 |
| Aug 29, 2026 | 63 |
| Aug 28, 2026 | 63 |
| Aug 27, 2026 | 64 |
| Aug 26, 2026 | 64 |
| Aug 25, 2026 | 64 |
| Aug 24, 2026 | 62 |
| Aug 23, 2026 | 65 |
| Aug 22, 2026 | 65 |
| Aug 20, 2026 | 64 |
| Aug 19, 2026 | 64 |
| Aug 18, 2026 | 64 |
| Aug 17, 2026 | 65 |
| Aug 16, 2026 | 63 |
| Aug 15, 2026 | 64 |
| Aug 14, 2026 | 63 |
| Aug 13, 2026 | 63 |
| Aug 12, 2026 | 63 |
| Aug 11, 2026 | 62 |
| Aug 10, 2026 | 62 |
| Aug 9, 2026 | 64 |
| Aug 8, 2026 | 64 |
| Aug 7, 2026 | 63 |
| Aug 6, 2026 | 60 |
| Aug 5, 2026 | 60 |
| Aug 3, 2026 | 62 |
| Aug 2, 2026 | 60 |
| Jul 31, 2026 | 72 |
| Jul 30, 2026 | 73 |
| Jul 29, 2026 | 74 |
| Jul 28, 2026 | 64 |
| Jul 27, 2026 | 63 |
| Jul 26, 2026 | 66 |
| Jul 25, 2026 | 66 |
Key facts
- Market cap
- $7.0B
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Beta
- 1.22
- Risk grade (1–10)
- 4
- Next earnings
- Nov 3, 2026
Drug Manufacturers - Specialty & Generic peers
| Company | Market cap | Score |
|---|---|---|
| RDY Dr. Reddy's Laboratories | $11.0B | 53 |
| ALKS Alkermes | $7.3B | 58 |
| HIMS Hims & Hers Health | $6.8B | 54 |
| LNTH Lantheus | $6.5B | 66 |
| KNSA Kiniksa Pharmaceuticals International | $6.2B | 65 |
| RGC Regencell Bioscience Holdings | $5.4B | 38 |
Questions
What is AMRX's stock score today?
AMRX scores 65/100 (Neutral) as of Oct 21, 2026: technical 72, fundamental 59. Scores are recomputed every night.
Is AMRX a buy?
The score is not a buy or sell recommendation. A 65 says the technical and fundamental signals we measure lean neutral today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.
How is the AMRX score calculated?
102 weighted scorers feed it today: 40 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 5 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.
Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.